表紙
市場調査レポート

アルツハイマー治療薬の世界市場動向・機会・予測 2015-2020年:画像・治療法・診断・バイオマーカー

Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts 2015-2020

発行 Azoth Analytics 商品コード 346774
出版日 ページ情報 英文 106 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
アルツハイマー治療薬の世界市場動向・機会・予測 2015-2020年:画像・治療法・診断・バイオマーカー Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts 2015-2020
出版日: 2015年12月08日 ページ情報: 英文 106 Pages
概要

世界のアルツハイマー市場は、2015年から2020年にかけて8.54%のCAGRを示すと予測されています。地域別ではアジア太平洋地域が2014年における収益シェアの大部分を構成し、2020年までこの傾向が続くと予測されています。

当レポートでは、世界のアルツハイマー病市場について調査し、市場規模・シェア・予測、セグメント別の分析 (治療法・診断&バイオマーカー・画像部門・患者・治療薬) 、政策・規制環境、市場動向の変化と新しい機会、競合情勢と戦略的提言、および主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 アルツハイマー病市場の概要

第3章 世界のアルツハイマー病市場の展望

第4章 世界のアルツハイマー病市場

  • 治療法別
  • 診断法・バイオマーカー別
  • 画像部門別
  • 病態修飾療法 (DMT) 別

第5章 世界のアルツハイマー病市場の展望:人口動態別 (年齢グループ)

第6章 世界のアルツハイマー病市場の展望:治療薬別

第7章 世界のアルツハイマー病市場の展望:地域別

第8章 米国のアルツハイマー病市場の展望

  • 米国の認知症市場の展望

第9章 世界の認知症市場の展望

第10章 世界の認知症市場の展望

  • 地域別の分析
    • アジア太平洋の認知症市場の展望
  • 国別
    • 低所得国別の分析
    • 上位10ヵ国の分析

第11章 市場ダイナミクス

  • 促進因子
  • 課題

第12章 市場動向・発展

第13章 競合情勢

  • 売上比較:上位5社
  • EBITDA比較:上位5社
  • EBIT比較:上位5社
  • PBT比較:上位5社
  • PAT比較:上位5社
  • 流動比率比較:上位5社

第14章 企業プロファイル

  • Pfizer Inc.
  • Novartis International AG
  • Axovant Sciences Ltd.
  • Acadia Pharmaceuticals
  • Biotie Therapies

図表リスト

目次

Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimer's Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer's market in the coming years.

According to Azoth Analytics research report, “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)”, global Alzheimer's market is projected to exhibit a CAGR of over 8.54% during 2015-2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer's Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer's Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: >65 years, <65 years; By Region; Global Dementia Market)” analyzes the following aspects of global Alzheimer's market:

  • Global Alzheimer's Market Size, Share & Forecast
  • Segmental Analysis - By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
  • Policy & Regulatory Landscape
  • Market Entry Strategies for Domestic/Foreign Players
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • 1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally.
  • 2. To identify the on-going trends and anticipated growth in the next five years
  • 3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies
  • 4. To obtain research based business decision and add weight to presentations and marketing material
  • 5. To gain competitive knowledge of leading players
  • 6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer's specific needs

Table of Contents

1. Research Methodology

2. Alzheimer's Disease Market Overview

3. Global Alzheimer's Disease Market Outlook

4. Global Alzheimer's Disease Market

  • 4.1. By Therapeutics
  • 4.2. By Diagnostics and Biomarkers
  • 4.3. By Imaging Sector
  • 4.4. By Disease Modifying Therapeutics

5. Global Alzheimer's Disease Market Outlook-By Demographic (Age-Group)

6. Global Alzheimer's Disease Market Outlook-By Drug

7. Global Alzheimer's Disease Market Outlook-By Region

8. United States Alzheimer's Disease Market Outlook

  • 8.1. United States Dementia Market Outlook

9. Global Dementia Disease Market Outlook

10. Global Dementia Disease Market Outlook

  • 10.1. By Regional Break-Up
    • 10.1.1. Asia-Pacific Dementia Market Outlook
  • 10.2. By Countries
    • 10.2.1. Low Income Country -wise Break up
    • 10.2.2. Top Ten Country-wise Break-Up
      • Australia Dementia Market Outlook
      • UK Dementia Market Outlook

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Sales Comparatives, Top 5 Companies
  • 13.2. EBITDA Comparatives, Top 5 Companies
  • 13.3. EBIT Comparatives, Top 5 Companies
  • 13.4. PBT Comparatives, Top 5 Companies
  • 13.5. PAT Comparatives, Top 5 Companies
  • 13.6. Current Ratio Comparatives, Top 5 Companies

14. Company Profiling

  • 14.1. Pfizer Inc.
  • 14.2. Novartis International AG
  • 14.3. Axovant Sciences Ltd.
  • 14.4. Acadia Pharmaceuticals
  • 14.5. Biotie Therapies
  • 1. Global Alzheimer's Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 2. Global Alzheimer's Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
  • 3. Global Alzheimer's Market share, By Therapeutics
  • 4. Global Alzheimer's Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
  • 5. Global Alzheimer's Disease Market, By Imaging Sector, By Value (USD Million)
  • 6. Global Alzheimer's Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
  • 7. Global Alzheimer's Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million),2010-2020F
  • 8. Global Alzheimer's Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million),2010-2020F
  • 9. Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 10. United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
  • 12. U.S. Alzheimer's Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)
  • 13. U.S. Alzheimer's Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
  • 14. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 15. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 16. Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 17. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 18. Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
  • 19. Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
  • 20. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 21. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 22. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 23. Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 24. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 25. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 26. UK Dementia Market, By Type, 2014 (%)
  • 27. UK Dementia Cost, By Type of Service, 2014 (%)
  • 28. Number of Unpaid Caregivers (In Million)
  • 29. Pfizer Revenue (USD Million) AY 2011-2014
  • 30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 31. Pfizer Percentage Revenue, By Business Segment (2014)
  • 32. Pfizer Percentage Revenue, By Geography (2014)
  • 33. Novartis International AG Revenue (USD Million) AY 2011-2014
  • 34. Novartis International AG Percentage Revenue, By Business Segment (2014)
  • 35. Novartis International AG Percentage Revenue, By Geography (2014)
  • 36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
  • 38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
  • 39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
  • 40. Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
  • 41. Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
  • 42. Biotie Therapies Revenue (USD Million) AY 2011-2014
  • 43. Biotie Therapies Percentage Revenue, By Business Segment (2014)
  • 44. Sales Comparatives, Top 5 Companies, 2011-2014
  • 45. EBITDA Comparatives, Top 5 Companies, 2011-2015
  • 46. EBIT Comparatives, Top 5 Companies, 2011-2015
  • 47. PBT Comparatives, Top 5 Companies, 2011-2015
  • 48. PAT Comparatives, Top 5 Companies, 2011-2015
  • 49. Current Ratio Comparatives, Top 5 Companies, 2011-2015
  • 50. Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
  • 51. Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
Back to Top